ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements
Modern Diagnostic & Research Centre will hold a board meeting on November 14, 2026. The meeting will consider unaudited standalone half-yearly results to September 2026.
The company submitted the Regulation 74(5) certificate for the half-year ended September 30, 2026, confirming depository participant compliance, alongside a nil investor grievance report.
Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and auditor reappointment.
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre approved various routine matters, including AGM notice, director reappointment, and statutory auditor reappointment. It also terminated a Jaipur laboratory management agreement.
Modern Diagnostic & Research Centre Limited scheduled a board meeting for September 3, 2026, to discuss administrative agenda items including AGM notices and reports.
Modern Diagnostic & Research Centre Ltd reported revenue from operations of ₹39.9 Cr and net profit of ₹2.1 Cr for H2 FY26.
Modern Diagnostic & Research Centre reported total income of ₹84.14 Crore for FY26. The board approved audited results with a basic EPS of ₹3.48.
Modern Diagnostic & Research Centre scheduled a board meeting on May 29, 2026. Directors will consider and approve annual audited financial results for fiscal 2026.
Modern Diagnostic & Research Centre approved extending IPO proceeds utilization and GCP fund reallocation. The board also discussed restoring previously shutdown IT systems.
Modern Diagnostic & Research Centre scheduled a board meeting for May 13, 2026. Directors will discuss extending project completion timelines and utilizing IPO proceeds.